|
DK455088D0
(da)
|
1988-08-12 |
1988-08-12 |
Symbicom Ab |
Syntetiske receptoranaloger
|
|
EP0576592B1
(en)
|
1991-03-18 |
2000-05-31 |
The Scripps Research Institute |
Oligosaccharide enzyme substrates and inhibitors: methods and compositions
|
|
US5620864A
(en)
|
1992-06-29 |
1997-04-15 |
Health Research, Inc. |
Acceptor for fucosyl transferase
|
|
DK76193D0
(da)
|
1993-06-25 |
1993-06-25 |
Astra Ab |
Kulhydratderivater
|
|
DE19643764A1
(de)
|
1996-09-30 |
1998-04-02 |
Bayer Ag |
Glycokonjugate von modifizierten Camptothecin-Derivaten (20-0-Verknüpfung)
|
|
DE19654180A1
(de)
|
1996-12-23 |
1998-06-25 |
Hoechst Ag |
Phosphane, Verfahren zu ihrer Herstellung und ihre Verwendung in Metallkomplexen
|
|
US6323176B1
(en)
|
1998-02-25 |
2001-11-27 |
Eli Lilly And Company |
Cyclic peptide antifungal agents
|
|
JP2002532513A
(ja)
|
1998-12-16 |
2002-10-02 |
イーライ リリー アンド カンパニー |
糖置換基を有する環式ペプチド抗真菌剤
|
|
SE0100172D0
(sv)
|
2001-01-22 |
2001-01-22 |
Ulf Nilsson |
New inhibitors against galectins
|
|
FR2835527B1
(fr)
|
2002-02-05 |
2004-03-12 |
Centre Nat Rech Scient |
Synthese de molecules de type inositolphosphate glycanne: traitement des troubles de la proliferation cellulaire et des desordres metaboliques caracterises par une resistance a l'insuline
|
|
AUPS213802A0
(en)
|
2002-05-03 |
2002-06-06 |
Alchemia Pty Ltd |
Disaccharides for drug discovery
|
|
CA2528152A1
(en)
|
2003-06-03 |
2005-01-06 |
The Regents Of The University Of California |
Compositions and methods for treatment of disease with acetylated disaccharides
|
|
CN1906203A
(zh)
|
2003-12-23 |
2007-01-31 |
普罗吉恩工业有限公司 |
葡糖胺基聚糖(gag)模拟物
|
|
SE0401301D0
(sv)
|
2004-05-21 |
2004-05-21 |
Forskarpatent I Syd Ab |
Novel 3-triazolyl-galactoside inhibitors of galectins
|
|
SE0401300D0
(sv)
|
2004-05-21 |
2004-05-21 |
Forskarpatent I Syd Ab |
Novel Galactoside Inhibitors of Galectins
|
|
EP1632498A1
(en)
|
2004-09-03 |
2006-03-08 |
Syngenta Participations AG |
Derivatives of avermectin, avermectin monosaccharide and avermectin aglycone
|
|
CN101291946B
(zh)
|
2005-08-09 |
2011-06-29 |
糖模拟物有限公司 |
对来自假单胞菌的pa-il凝集素、pa-iil凝集素或其两者的糖模拟物抑制剂
|
|
EP2001487A4
(en)
|
2006-03-15 |
2010-09-15 |
Tufts College |
FLUORINATED CARBOHYDRATES AND THEIR USE IN THE VISUALIZATION OF TUMORS, TISSUE TREATMENT AND CANCER CHEMOTHERAPY
|
|
US20090176717A1
(en)
|
2006-06-01 |
2009-07-09 |
Glycomimetics, Inc. |
Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
|
|
GB0614947D0
(en)
|
2006-07-27 |
2006-09-06 |
Isis Innovation |
Epitope reduction therapy
|
|
EP1964846A1
(en)
|
2007-02-27 |
2008-09-03 |
Bracco Imaging, S.P.A. |
Process for the preparation of contrast agents
|
|
GB0712494D0
(en)
|
2007-06-27 |
2007-08-08 |
Isis Innovation |
Substrate reduction therapy
|
|
KR102256410B1
(ko)
|
2008-04-08 |
2021-05-26 |
슬로안-케테링인스티튜트퍼캔서리서치 |
트리테르펜 사포닌, 그의 합성 방법, 및 그의 용도
|
|
ES2543063T3
(es)
|
2008-05-16 |
2015-08-14 |
Galecto Biotech Ab |
Nueva síntesis de inhibidores de galactósidos
|
|
JP5809560B2
(ja)
|
2008-10-08 |
2015-11-11 |
アビヴァックス |
インフルエンザに対して使用するためのワクチン組成物
|
|
ES2652488T3
(es)
|
2009-04-28 |
2018-02-02 |
Galecto Biotech Ab |
Nuevos inhibidores de galactósidos de galectinas
|
|
WO2011002673A1
(en)
|
2009-07-01 |
2011-01-06 |
Temple University - Of The Commonwealth System Of Higher Education |
Leptin agonist and methods of use
|
|
US9624255B2
(en)
|
2009-08-11 |
2017-04-18 |
Arizona Board Of Regents |
Carbohydrate-mediated tumor targeting
|
|
WO2011129314A1
(ja)
|
2010-04-13 |
2011-10-20 |
和光純薬工業株式会社 |
糖類の重水素化方法
|
|
US9243021B2
(en)
|
2012-10-31 |
2016-01-26 |
Galecto Biotech Ab |
Galactoside inhibitor of galectins
|
|
EP2620443A1
(en)
|
2012-01-25 |
2013-07-31 |
Galecto Biotech AB |
Novel galactoside inhibitors of galectins
|
|
WO2013170985A1
(en)
|
2012-05-18 |
2013-11-21 |
Boettger Erik C |
New aminoglycoside antibiotics targeting bacterial 16s ribosomal rna lacking ototoxicity
|
|
EP2859112A4
(en)
|
2012-06-08 |
2015-10-28 |
Glycom As |
PROCESS FOR THE PREPARATION OF OLIGOSACCHARIDES AND OLIGOSACCHARIDE GLYCOSIDES BY FERMENTATION
|
|
GB201214736D0
(en)
|
2012-08-17 |
2012-10-03 |
Isis Innovation |
Inflammation imaging and therapy
|
|
CN105142672B
(zh)
|
2012-10-23 |
2019-04-05 |
西纳福克斯股份有限公司 |
经修饰的抗体、抗体-缀合物及其制备方法
|
|
CN104755088A
(zh)
|
2012-10-31 |
2015-07-01 |
格莱克特生物技术公司 |
半乳凝集素-3的半乳糖苷抑制剂及其用于治疗肺纤维化的应用
|
|
EP2919802A4
(en)
|
2012-11-15 |
2016-09-14 |
Univ Tufts |
METHOD, COMPOSITIONS AND KITS FOR TREATING, MODULATING OR PREVENTING ANGIOGENESIS OR FIBROSIS IN A PATIENT USING A GALECTINE PROTEIN HEMMER
|
|
GB2511137A
(en)
|
2013-02-26 |
2014-08-27 |
Glykos Finland Oy |
Chelator Molecule
|
|
EP2968215B1
(en)
|
2013-03-14 |
2021-05-05 |
The Regents of the University of California |
Thiosaccharide mucolytic agents
|
|
PL2991683T3
(pl)
|
2013-05-02 |
2020-03-31 |
Glykos Finland Oy |
Koniugaty glikoproteiny lub glikanu z toksycznym ładunkiem
|
|
WO2015155207A1
(en)
|
2014-04-08 |
2015-10-15 |
Galecto Biotech Ab |
Galactoside inhibitors for the treatment of alpha-synucleinopthies
|
|
FR3020952B1
(fr)
|
2014-05-14 |
2017-09-08 |
Adocia |
Formulation a action rapide d'insuline comprenant un compose anionique substitue et un compose polyanionique
|
|
ES3002778T3
(en)
|
2014-06-27 |
2025-03-07 |
Glycom As |
Oligosaccharide production
|
|
JP6735680B2
(ja)
|
2014-07-09 |
2020-08-05 |
ガレクト バイオテック エービー |
ガレクチンの新規ハイブリッドガラクトシド阻害剤
|
|
US20170274087A1
(en)
|
2014-09-19 |
2017-09-28 |
Emory University |
Saccharide analogs and agents for the diagnosis and therapy of bacterial infections
|
|
JP6707548B2
(ja)
|
2015-01-16 |
2020-06-10 |
ガレクト・バイオテック・エイビイ |
ガレクチンの新規なガラクトシド阻害剤
|
|
CA2970062C
(en)
|
2015-01-30 |
2023-02-28 |
Galecto Biotech Ab |
Alpha-d-galactoside inhibitors of galectins
|
|
WO2016180483A1
(en)
|
2015-05-12 |
2016-11-17 |
Galecto Biotech Ab |
Once-daily treatment of pulmonary fibrosis
|
|
WO2017019770A1
(en)
|
2015-07-27 |
2017-02-02 |
Wayne State University |
Compositions and methods relating to galectin detection
|
|
CA3000924A1
(en)
|
2015-11-09 |
2017-05-18 |
Galecto Biotech Ab |
Novel galactoside inhibitors of galectins
|
|
CA3025867A1
(en)
*
|
2016-07-12 |
2018-01-18 |
Galecto Biotech Ab |
Alpha-d-galactoside inhibitors of galectins
|
|
EP3621973A4
(en)
|
2017-05-12 |
2021-10-27 |
Galectin Sciences, LLC |
COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DISEASES AND USES THEREOF
|
|
KR20200015528A
(ko)
|
2017-05-12 |
2020-02-12 |
갈랙틴 사이언시즈, 엘엘씨 |
전신 인슐린 내성 질환의 치료용 화합물 및 그의 용도
|
|
WO2019067702A1
(en)
|
2017-09-27 |
2019-04-04 |
Bristol-Myers Squibb Company |
INHIBITORS WITH SMALL MOLECULES OF GALECTIN-3
|
|
US11072626B2
(en)
|
2017-10-11 |
2021-07-27 |
Bristol-Myers Squibb Company |
Small molecule inhibitors of Galectin-3
|
|
KR20200104889A
(ko)
|
2017-12-29 |
2020-09-04 |
글리코미메틱스, 인크. |
E-셀렉틴 및 갈렉틴-3의 이종이기능성 억제제
|
|
US11845771B2
(en)
|
2018-12-27 |
2023-12-19 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of E-selectin and galectin-3
|
|
CA3122321A1
(en)
|
2018-12-27 |
2020-07-02 |
Glycomimetics, Inc. |
Galectin-3 inhibiting c-glycosides
|
|
JP2022529806A
(ja)
|
2019-04-24 |
2022-06-24 |
グリコミメティクス， インコーポレイテッド |
Ｅ－セレクチン、ガレクチン－３、および／またはｃｘｃｒ４ケモカイン受容体のガラクトース連結型多量体糖模倣性阻害剤
|
|
WO2021086816A1
(en)
|
2019-10-29 |
2021-05-06 |
Glycomimetics, Inc. |
Galectin-3 inhibiting c-glycosides
|